What most articles get wrong about "Roco results" Most online content about Roco weight loss conflates three separate things: Semaglutide clinical trial results (15-17% mean weight loss over 68 weeks in STEP 1) Real-world results from brand-name Wegovy (slightly lower, approximately 12-14% mean weight loss, due to lower adherence and higher discontinuation rates) Results from compounded semaglutide products marketed as Roco The error is claiming "Roco results" as if Roco is a distinct product with its own evidence base
Like other GLP-1 pathway drugs, orforglipron interacts with peripheral and central signaling to regulate appetite and metabolism, including delayed gastric emptying and improved post-prandial control
Research is ongoing, and Im genuinely interested to see what future studies will reveal
For instance, four well-known nutraceuticals-RSV, CUR, PPR, and QUE-have been extensively studied for their protective effects on human health (Figure 1)
At the end of the trial, 73% of adolescents in the semaglutide group had a reduction in body weight of 5% or greater compared with 18% of those in the placebo group
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
